Comparing the efficacy between 0.09% cyclosporine, 0.05% cyclosporine, and 5% lifitegrast in patients with dry eye disease

被引：0
|
作者：
Kolluru, Ajay [1 ]
Nguyen, Annie [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1565-A0290
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comparison of Subjective Responses to Cyclosporine 0.05% Versus Lifitegrast 5.0% in Individuals With Dry Eye Disease
    Locatelli, Elyana Vittoria Tessa
    Acuna, Kelly Ann
    Betz, Jason
    Tovar, Arianna Alicia
    Galor, Anat
    [J]. CORNEA, 2024, 43 (01) : 88 - 94
  • [2] Comparison of subjective responses to cyclosporine 0.05% versus lifitegrast 5.0% in individuals with dry eye disease
    Locatelli, Elyana
    Acuna, Kelly
    Tovar, Arianna
    Betz, Jason
    Galor, Anat
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Safety and Efficacy of Cyclosporine (0.05% versus 0.09%) in Dry Eye Disease. Is it the Strength of Cyclosporin that Really Matters?
    Rajpoot, Mukesh
    Singh, Divya
    Pandey, Kankambari
    Bhargava, Rahul
    [J]. NEPALESE JOURNAL OF OPHTHALMOLOGY, 2022, 14 (02) : 64 - 77
  • [4] Cyclosporine 0.09% Solution (Cequa) for Dry Eye Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1577): : 116 - 118
  • [5] CYCLOSPORINE OPHTHALMIC SOLUTION 0.09% IMPROVES THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE IN PATIENTS WHOSE DISEASE IS INADEQUATELY CONTROLLED ON CYCLOSPORINE OPHTHALMIC EMULSION 0.05%
    Johnston, J.
    Adler, R.
    Hessen, M.
    Nichols, K.
    Pflugfelder, S.
    Truett, K.
    Urbieta, M.
    Reynolds, R.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S32 - S32
  • [6] The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjogren's syndrome
    Deveci, Hulya
    Kobak, Senol
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2014, 34 (05) : 1043 - 1048
  • [7] The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren’s syndrome
    Hülya Devecı
    Senol Kobak
    [J]. International Ophthalmology, 2014, 34 : 1043 - 1048
  • [8] Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease
    Perez-Rico, Consuelo
    Germain, Francisco
    Castro-Rebollo, Maria
    Mareno-Salgueiro, Agustin
    Angel Teus, Miguel
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (04) : 471 - 474
  • [9] Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease
    Consuelo Pérez-Rico
    Francisco Germain
    María Castro-Rebollo
    Agustín Moreno-Salgueiro
    Miguel ngel Teus
    [J]. International Journal of Ophthalmology, 2013, (04) : 471 - 474
  • [10] Topical Cyclosporine 0.05% for the Prevention of Dry Eye Disease Progression
    Rao, Sanjay N.
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (02) : 157 - 163
12345